首都医科大学学报 ›› 2019, Vol. 40 ›› Issue (2): 263-268.doi: 10.3969/j.issn.1006-7795.2019.02.020

• 基础研究 • 上一篇    下一篇

Dppz配体10,13-位由芳香基取代的新型单核钌配合物的合成

李敏娜   

  1. 首都医科大学药学院化学生物学系, 北京 100069
  • 收稿日期:2018-04-24 出版日期:2019-03-21 发布日期:2019-04-15
  • 通讯作者: 李敏娜 E-mail:minnali78@126.com
  • 基金资助:
    国家自然科学基金青年基金(21708027),北京市科技计划面上项目(SQKM201210025006),首都医科大学自然科学基金(2015ZR17)。

Synthesis of novel mononuclear Ru(Ⅱ) complexes with 10,13-diaryl substituents on the dppz ligands

Li Minna   

  1. Department of Chemical Biology, School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China
  • Received:2018-04-24 Online:2019-03-21 Published:2019-04-15
  • Supported by:
    This study was supported by National Natural Science Foundation for Young Scientist of China (21708027), Scientific Research Common Program of Beijing Municipal Commission of Education (SQKM201210025006), Natural Science Foundation of Capital Medical University in China (2015ZR17).

摘要: 目的 本论文以1,10-邻菲罗啉(1,10-phenanthroline,phen)为辅助配体,在主配体联吡啶类(3,2-a:2'-3'-c)吩嗪[pyrido-(3,2-a:2',3'-c)phenazine,dppz]的10,13-位分别引入噻吩、苯并噻吩、呋喃及苯并呋喃,设计并合成出对应4种新型单核二-(1,10-邻菲罗啉)-吡啶类(3,2-a:2'-3'-c)吩嗪合钌(Ⅱ)衍生物。方法 首先通过Suzuki偶联反应得到4种苯并噻二唑中间体,然后经CoCl2催化、NaBH4还原得到邻苯二胺类化合物,再经缩合反应得到对应的目标配合物。结果 苯并噻二唑中间体及对应的4种目标配合物通过磁共振氢谱、碳谱及高分辨质谱表征,紫外-可见吸收光谱进一步验证了目标配合物结构的正确性。结论 本论文通过多步反应合成出以1,10-邻菲罗啉为辅助配体,主配体dppz的10,13-位分别含有噻吩、苯并噻吩、呋喃及苯并呋喃的4种新型单核多吡啶钌配合物。紫外-可见吸收光谱实验表明尽管4种芳香取代基结构有差异,对应苯并噻二唑中间体和钌配合物的吸收光谱相似。

关键词: 钌配合物, 联吡啶类(3, 2-a:2'-3'-c)吩嗪配体, 10, 13-芳香基取代

Abstract: Objective Four new ruthenium complexes with 1,10-phenanthroline ancillary ligand and 10, 13-position substituted[pyrido-(3,2-a:2',3'-c)phenazine,dppz] major ligands including thiophenyl,furanyl,[2-benzo(b)thienyl]-2,1,3-benzothiadiazole and[2-benzo(b)furanyl]-2,1,3-benzothiadiazole will be designed and synthesized. Methods Target complexes were made by condensation reaction of ruthenium complex with the appropriate 3,6-diaryl substituted benzene-1,2-diamine. The latter 3,6-diaryl substituted benzene-1,2-diamine was obtained by a Suzuki-coupling reaction, and subsequently by reduction with NaBH4 under catalysis of CoCl2. Results Benzothiadiazole intermediates and corresponding target complexes are well characterized by 1H nuclear magnetic resonance (NMR), 13C NMR and TOF-Mass. UV-vis absorption spectra of all ruthenium complexes further verify the structures of the target complexes. Conclusion In this paper, we have synthesized four mononuclear ruthenium complexes with 1,10-phenanthroline ancillary ligand and 10, 13-diaryl including thiophenyl,furanyl,[2-benzo(b)thienyl]-2,1,3-benzothiadiazole and[2-benzo(b)furanyl]-2,1,3-benzothiadiazole, substituted dppz as major ligand through multiple steps. Both four 4,7-position substituted 2,1,3-benzothiadiazole intermediates and corresponding ruthenium complexes exhibit substantially similar absorption spectra despite the structural difference.

Key words: ruthenium complexes, pyrido-(3,2-a:2',3'-c)phenazine ligand, 10,13-diaryl substituted

中图分类号: